EZH2 and Miyoshi myopathy: Dimopoulos and colleagues found that combination of 5-Aza and EZH2 inhibitor EPZ-6438, and less significantly combination of HDAC inhibitor panabinostat and EPZ-6438 could resensitize MM cell lines with acquired resistance to IMiD [26].